Anixa Bioscience News Today

HC Wainwright reaffirmed their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $12.00 price objective on the stock. HC Wainwright also issued estimates for Anixa Biosciences’ FY2025 earnings at ($0.40) EPS. Anixa Biosciences Price Performance […]

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

A new vaccine hopes to protect against one of the more deadly forms of the cancer, and an Orlando woman was the first to take it! FOX 35 News introduced you to Jenni Davis back in April.

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Anixa Biosciences, Inc. (NASDAQ:ANIX – Free Report) – Investment analysts at Chardan Capital issued their FY2023 earnings estimates for Anixa Biosciences in a research note issued to investors on Monday, July 10th. Chardan Capital analyst M. Barcus expects that the company will post earnings of ($0.45) per share for the year. Chardan Capital has a […]

Chardan Capital reaffirmed their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Get Rating) in a research report report published on Wednesday, MarketBeat Ratings reports. They currently have a $9.00 target price on the stock, up from their previous target price of $8.00. Chardan Capital also issued estimates for Anixa Biosciences’ FY2024 earnings at […]

Chardan Capital reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Get Rating) in a research note published on Wednesday morning, Marketbeat.com reports. They currently have a $9.00 target price on the stock, up from their previous target price of $8.00. Chardan Capital also issued estimates for Anixa Biosciences’ FY2024 earnings at $4.61 […]

Anixa Biosciences, Inc. (NASDAQ:ANIX – Get Rating) – Stock analysts at Chardan Capital issued their FY2024 EPS estimates for shares of Anixa Biosciences in a research note issued on Wednesday, March 22nd. Chardan Capital analyst M. Barcus forecasts that the company will post earnings per share of $4.61 for the year. Chardan Capital has a […]

Cancer Vaccines Drug Pipeline Market Size By Product Type (Prophylactic Vaccine and Therapeutic Vaccine), By End-User (Hospital and Ambulatory Care...

/PRNewswire/ -- The "Global Cancer Vaccine Market & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.coms offering. The global cancer...